scholarly journals Three-Dimensional Evaluation of the Depressor Anguli Oris and Depressor Labii Inferioris for Botulinum Toxin Injections

Author(s):  
You-Jin Choi ◽  
Young-Jun We ◽  
Hyung-Jin Lee ◽  
Kang-Woo Lee ◽  
Young-Chun Gil ◽  
...  

Abstract Background Botulinum toxin type A (BoNT-A) injection administered at an inappropriate site or depth can produce an unwanted change in facial animation because the depressor anguli oris (DAO) and depressor labii inferioris (DLI) muscles are partially overlapped. Therefore, simple BoNT-A injection guidelines, based on 3-dimensional (3D) facial anatomic references and landmarks, would be very useful. Objectives The aim of this study was to establish novel BoNT-A injection guidelines that include the soft tissue thickness at the lower perioral region. Data were acquired with a 3D scanning system combined with dissections in order to obtain accurate injection sites and depths for the DAO and DLI. Methods 3D scans of the facial skin, superficial fat, and facial muscle surface were performed in 45 embalmed cadavers. The thicknesses of the skin and subcutaneous layer were calculated automatically from superimposed images at each of 5 reference points (P) in the perioral region. Results In every case (100%), P3 and P5 were located in the DLI and DAO areas, respectively (45/45). Therefore, we defined P3 as the “DLI point” and P5 as the “DAO point.” The soft tissue thicknesses at the DLI and DAO points were 6.4 [1.7] mm and 6.7 [1.8] mm, respectively. Conclusions The P3 and P5 described in this study are effective guidelines that only target the DLI and DAO. Clinicians, specifically, can easily use facial landmarks, such as the cheilion and pupil, to assign the DLI and DAO points without any measurement or palpation of the modiolus.

2010 ◽  
Vol 36 ◽  
pp. 2161-2166 ◽  
Author(s):  
WOO HYUN SHIM ◽  
SEUNG HYUN YOON ◽  
JU HYUN PARK ◽  
YOUNG-CHAN CHOI ◽  
SEONG TAEK KIM

2012 ◽  
Vol 130 (2) ◽  
pp. 376e-378e
Author(s):  
Jo Adriaens ◽  
Bram van Loon ◽  
Koen J. Ingels ◽  
Stefaan J. Bergé ◽  
Thomas J. Maal

Toxins ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 588
Author(s):  
Hyungkyu Bae ◽  
Jisoo Kim ◽  
Kyle K. Seo ◽  
Kyung-Seok Hu ◽  
Seong-Taek Kim ◽  
...  

The aim of the study was to propose a more efficient and safer botulinum toxin type A (BoNT-A) injection method for the masseter by comparing the conventional blind injection and a novel ultrasonography (US)-guided injection technique in a clinical trial. The 40 masseters from 20 healthy young Korean volunteers (10 males and 10 females with a mean age of 25.6 years) were included in this prospective clinical trial. The BoNT-A (24 U) was injected into the masseter of each volunteer using the conventional blind and US-guided injection techniques on the left and right sides, respectively, and analyzed by US and three-dimensional (3D) facial scanning. One case of PMB (paradoxical masseteric bulging) was observed on the side where a conventional blind injection was performed, which disappeared after the compensational injection. The reduction in the thickness of the masseter in the resting state differed significantly at 1 month after the injection between the conventional blind injection group and the US-guided injection group by 12.38 ± 7.59% and 17.98 ± 9.65%, respectively (t(19) = 3.059, p = 0.007). The reduction in the facial contour also differed significantly at 1 month after the injection between the conventional blind injection group and the US-guided injection group by 1.95 ± 0.74 mm and 2.22 ± 0.84 mm, respectively (t(19) = 2.908, p = 0.009). The results of the study showed that the US-guided injection method that considers the deep inferior tendon by visualizing the masseter can prevent the PMB that can occur during a blind injection, and is also more effective.


Sign in / Sign up

Export Citation Format

Share Document